Assyro AI

FDA Orange Book · active-ingredient family

Chlorothiazide

Chlorothiazide is approved as 2 brand and 12 generic applications in the FDA Orange Book, with their therapeutic-equivalence codes, listed patents, and marketing exclusivity.

Reference-listed drug:DIURIL · NDA 011870

2

Brand (NDA)

12

Generics (ANDA)

0

Listed patents

0

Exclusivity periods

Brand (NDA) products · suspension, tablet

ProductApplicantApplicationTEApproved
DIURILRLDSALIX PHARMSNDA 011870Approved Prior to Jan 1, 1982
DIURILRLD×2RISINGNDA 011145Approved Prior to Jan 1, 1982

Generic (ANDA) products (12)

ProductApplicantApplicationTEApproved
CHLOROTHIAZIDEWATSON LABSANDA 086795Aug 15, 1983
CHLOROTHIAZIDEWATSON LABSANDA 086796Aug 15, 1983
CHLOROTHIAZIDEWATSON LABSANDA 084026Sep 01, 1982
CHLOROTHIAZIDEHIKMA INTL PHARMSANDA 086028Jul 14, 1982
CHLOROTHIAZIDEHIKMA INTL PHARMSANDA 087736Jul 14, 1982
CHLOROTHIAZIDEABC HOLDINGANDA 085569Approved Prior to Jan 1, 1982
CHLOROTHIAZIDELEDERLEANDA 086940Approved Prior to Jan 1, 1982
CHLOROTHIAZIDELEDERLEANDA 086938Approved Prior to Jan 1, 1982
CHLOROTHIAZIDE×2PHARMOBEDIENTANDA 084217Approved Prior to Jan 1, 1982
CHLOROTHIAZIDESANDOZANDA 085485Approved Prior to Jan 1, 1982
CHLOROTHIAZIDEWATSON LABSANDA 085165Approved Prior to Jan 1, 1982
CHLOROTHIAZIDEWATSON LABSANDA 085173Approved Prior to Jan 1, 1982

Listed patents

No patents are listed against this product in the Orange Book. Listed patents reflect those the NDA holder submits under 21 U.S.C. 355 and are not exhaustive.

Chlorothiazide — frequently asked questions

Generics, reference-listed drug, patents, and exclusivity for this active ingredient, from the FDA Orange Book.

Agent CTA Background

Your Next Submission Could Take 6+ Fewer Weeks and Cost $250K Less.